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Introduction
Juvenile idiopathic arthritis (JIA) is a multifactor chronic
inflammatory joints disease that is characterized by long
progressive course leading to development of contrac-
tures and loss of joint´s function. Currently, there are
only several laboratory and radiological predictors of
unfavorable prognosis of JIA. In recent years, scientists
studied the molecular basis of the development and
maintenance of chronic inflammation in the joint.
Reduced sensitivity of cells to apoptosis is one the possi-
ble mechanisms contribution to progressive inflamma-
tion in synovial membrane. Polymorphisms Arg72Pro
4 exon, ins/del 16bp intron 3 and G13964C intron 6
gene P53 may change expression gene P53 and func-
tional activity this protein, main factor of intrinsic apop-
tosis pathway (P.Dumont et al 2003; A.Sallivan et al,
A.Ghosh et al 2004).
Objectives
Identify predicting factors of course and outcome of JIA
in children by based on comprehensive analysis of the
clinical and instrumental, laboratory and molecular
genetic tests.
Methods
Clinical, serological, x-ray manifestations, ultrasound
and MRI data were analyzed in 126 children with JIA.
Three polymorphisms gene P53 were detected by PCR-
RFLP. 60 healthy children without family history of any
autoimmune disease were controls.
Results
We haven’t revealed significant differences distribution
genotypes of Arg72Pro ex4, ins/del16bp in3 and
G13964C in6 gene P53 between children with JIA and
controls. But girls with oligo- and polyarthritis with gen-
otypes containing three or more minor polymorphic
variant 72Pro, ins16bp, 13964C gene P53 in any combi-
nation were with more severe variant articular lesion.
By means of ROC-curve analysis and regression meth-
ods were assessed the contribution of molecular genetic,
clinical, instrumental and laboratory factors on the dis-
ease with a view to determine the prognostic signifi-
cance of these factors. The presence of erosions of the
joints and carrier of genotypes containing allele 72Pro
gene P53 were found in girls with JIA like highly infor-
mation signs of prognosis “active” arthritis and the pre-
sence of erosions and debut JIA under the age of
3 years old - for boys. Also two signs were obtained for
predicting remission in girls with JIA it´s early treat-
ment by DMARS and carrier of homogenous genotype
containing allele Arg72 gene P53.
Conclusion
In order to predict the nature of the disease and to iden-
tify children with risk group of the worst course of JIA is
possible to use molecular genetic testing of gene P53 in
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